Differential expression of cytochrome P450 isoforms in the lungs of septic animals

Critical Care Medicine

Volumn 32, Issue 5, 2004, Pages 1186-1191

  Cui, Xiaoxuan ^a   Wu, Rongqian ^a   Zhou, Mian ^a   Simms, H Hank ^a   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b N Shore Long Isl Jewish Res Inst ^*  (United States)

Author keywords

CYP2C11; CYP2J4; CYP4A3; Epoxyeicosatrienoic acids; Lungs

Indexed keywords

CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 2C11; CYTOCHROME P450 2J4; CYTOCHROME P450 4A; CYTOCHROME P450 4A3; ISOPROTEIN; MESSENGER RNA; MICROSPHERE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BACTERIUM CONTAMINATION; BLOOD VESSEL; CARDIOVASCULAR RESPONSE; CECUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLUID THERAPY; GENE EXPRESSION; HEMODYNAMICS; INTESTINE PERFORATION; LIGATION; LUNG; LUNG PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOACTIVITY; RANDOMIZATION; RAT; RAT STRAIN; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; UPREGULATION; VASCULAR RESISTANCE; WESTERN BLOTTING;

ANIMALS; ARACHIDONIC ACID; ARYL HYDROCARBON HYDROXYLASES; BLOOD PRESSURE; CARDIAC OUTPUT; CECUM; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HYDROXYEICOSATETRAENOIC ACIDS; LIGATION; LUNG; MALE; PROTEIN ISOFORMS; PUNCTURES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; STEROID 16-ALPHA-HYDROXYLASE; TIME FACTORS; UP-REGULATION; VASCULAR RESISTANCE;

EID: 2442487903     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000124877.86743.37     Document Type: Article

References (38)

1. Yang S, Chung CS, Ayala A, et al: Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 2002; 17:55-60
2. Zeldin DC, Plitman JD, Kobayashi J, et al: The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway. Characterization and significance. J Clin Invest 1995; 95:2150-2160
3. Roman RJ: P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82:131-185
4. Zeldin DC: Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001; 276:36059-36062
5. Fuloria M, Smith TK, Aschner JL: Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone. Am J Physiol Lung Cell Mol Physiol 2002; 283:L383-L389
6. Nguyen X, Wang MH, Reddy KM, et al: Kinetic profile of the rat CYP4A isoforms: Arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol 1999; 276:R1691-R1700
7. Ma YH, Gebremedhin D, Schwartzman ML, et al: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993; 72:126-136
8. Birks EK, Bousamra M, Presberg K, et al: Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue. Am J Physiol 1997; 272:L823-L829
9. VanRollins M, Kaduce TL, Fang X, et al: Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem 1996; 271:14001-14009
10. Pampori NA, Shapiro BH: Nominal growth hormone pulses in otherwise normal masculine plasma profiles induce intron retention of overexpressed hepatic CYP2C11 with associated nuclear splicing deficiency. Endocrinology 2000; 141:4100-4106
11. Wang MH, Guan H, Nguyen X, et al: Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol 1999; 276:F246-F253
12. Morrison AM, Wang P, Chaudry IH: A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis. Shock 1996; 6:46-51
13. Aoki N, Siegfried M, Lefer AM: Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol 1989; 256:H1509-H1512
14. Baveja R, Kresge N, Ashburn JH, et al: Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock 2002; 18:415-422
15. Buerke M, Sibelius U, Grandel U, et al: Staphylococcus aureus alpha toxin mediates polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Shock 2002; 17:30-35
16. Zhao H, Spain DA, Matheson PJ, et al: Progressive decrease in constrictor reactivity of the non-absorbing intestine during chronic sepsis. Shock 2001; 16:40-43
17. Campbell WB, Harder DR: Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 1999; 84:484-488
18. Alkayed NJ, Birks EK, Hudetz AG, et al: Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996; 271:H1541-H1546
19. Alkayed NJ, Narayanan J, Gebremedhin D, et al: Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 1996; 27:971-979
20. Fleming I: Cytochrome p450 and vascular homeostasis. Circ Res 2001; 89:753-762
21. Rosolowsky M, Campbell WB: Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1996; 1299:267-277
22. Li PL, Campbell WB: Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res 1997; 80:877-884
23. Zhu D, Bousamra M, Zeldin DC, et al: Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2000; 278:L335-L343
24. Stephenson AH, Sprague RS, Lonigro AJ: 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog. Am J Physiol 1998; 275:H100-H109
25. +-ATPase. J Clin Invest 1997; 99: 1224-1230
26. Zhu D, Birks EK, Dawson CA, et al: Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am J Physiol Heart Circ Physiol 2000; 279:H1526-H1533
27. Siewert E, Bort R, Kluge R, et al: Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 2000; 32:49-55
28. Morgan ET, Li-Masters T, Cheng PY: Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology 2002; 181-182:207-210
29. Crawford JH, Yang S, Zhou M, et al: Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med 2004; 32:502-508
30. Carcillo JA, Korzekwa KR, Jones GS, et al: The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity. Res Commun Mol Pathol Pharmacol 1998; 102:57-68
31. Jacobs ER, Effros RM, Falck JR, et al: Airway synthesis of 20-hydroxyeicosatetraenoic acid: Metabolism by cyclooxygenase to a bronchodilator. Am J Physiol 1999; 276:L280-L288
32. Scarborough PE, Ma J, Qu W, et al: P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 1999; 31:205-234
33. Fisslthaler B, Michaelis UR, Randriamboavonjy V, et al: Cytochrome P450 epoxygenases and vascular tone: Novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression. Biochim Biophys Acta 2003; 1619:332-339
34. Fisslthaler B, Hinsch N, Chataigneau T, et al: Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 2000; 36:270-275
35. Fisslthaler B, Popp R, Kiss L, et al: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401:493-497
36. Wang P, Chaudry IH: Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996; 270:R927-R938
37. Yang S, Cioffi WG, Bland KI, et al: Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J Trauma 1999; 47:706-712
38. Koo DJ, Zhou M, Chaudry IH, et al: The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J Surg Res 2001; 95:207-218